Search the Newsreel

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 July 2026

LUXEMBOURG, August 10, 2026--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of …

Eurofins: Weekly Report on Share Repurchases From 27th July to 31st July 2026

LUXEMBOURG, August 03, 2026--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS …

Eurofins: Weekly Report on Share Repurchases From 20th July to 24th July 2026

LUXEMBOURG, July 27, 2026--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS …

Is Eurofins Scientific (ENXTPA:ERF) Fairly Valued On Its €414 Million Share Buyback?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Eurofins Scientific (ENXTPA:ERF) has drawn fresh attention after completing a share buyback program totalling 7,029,661 shares, or 3.97% of its capital, for €414.45 million …

Eurofins Scientific (ENXTPA:ERF) Stock Looks Reasonable Despite A Wide Fair Value Gap

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Eurofins Scientific stock has delivered a decline of 28.9% over the past 5 years, yet a Discounted Cash Flow (DCF) intrinsic value estimate currently points …

Eurofins Scientific SE (ERFSF) (H1 2026) Earnings Call Highlights: Strong EPS Growth and Margin ...

This article first appeared on GuruFocus. EPS Growth: 29% increase year-on-year. Adjusted EBITDA Margin: 23.7%, exceeding expectations. Reported EBITDA Margin: 23.3%, with a 190 bps improvement year-on-year. Organic Growth: 2.7% for H1 2026. FX Headwind: 2.9% negative impact on revenue growth. Free Cash Flow: …

Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth

LUXEMBOURG, July 23, 2026--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Financial highlights in H1 2026 Basic EPS8 grew 29% to €1.55 in H1 2026 vs €1.20 in H1 2025, as Eurofins continued to accumulate the operational benefits from the five-year investment programme in its hub and …

Eurofins Scientific SE: Weekly Report on Share Repurchases from 13th July to 17th July 2026

LUXEMBOURG, July 20, 2026--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Weekly report on share repurchases from 13th July to 17th July 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number …

Eurofins Agrees to Acquire Element Materials Technology’s Life Sciences Testing Services Business in North America

LUXEMBOURG, July 20, 2026--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific (EUFI.PA) (Paris:ERF), a global scientific leader in bioanalytical testing, has reached an agreement with Element Materials Technology ("Element") to acquire its Life Sciences Testing Services business in North America, for an enterprise value of $400m. The …

Eurofins Scientific SE: Konsensus der Analysten und Kursziel | A2QJCT | FR0014000MR3